Inrecent years, many women who have received IVF treatment are worried: Do ovulation-inducing drugs increase the risk of breast cancer? This article will combine the discussions of experts in reproductive medicine and breast surgery to reveal the truth.
1. How do drugs affect the breast?
1. How do ovulation-stimulating medications affect the mammary glands?
(FSH,HMG),10.The occurrence of breast cancer is associated with long-term high estrogen exposure, which theoretically poses a potential risk.
2. The research conclusions are still controversial

There is no significant risk for short-term use: The 2023 "Human Reproduction" study tracked 50,000 test-tube women and found that there was no difference in the incidence of breast cancer within one year of promoting expulsion and that of natural pregnancies (about 0.1%).
There are no significant risks associated with short-term use.In a study conducted in 2023 involving , 50,000 women who underwent IVF were tracked. It was found that the incidence of breast cancer within one year after ovulation induction was no different from that in the group of women with natural pregnancies (approximately 0.1%).
Long-term impacts need to be monitored closely:If a woman carries mutations in the BRCA1/2 gene, or if she undergoes ovulation stimulation more than three times a year, closer monitoring may be necessary.

3. Expert suggestions
nPre-treatment evaluation:Breast ultrasound/MRI examination is required for patients with a family history of breast cancer or breast nodules
Monitoring during treatment:Observe ovarian response every cycle by B-ultrasound to avoid excessive stimulation leading to a surge in estrogen
nPost-treatment follow-up:Women over 40 years old are recommended to have mammography every year and communicate with the attending doctor about the medication cycle.
Key points:,+.While nurturing life, we must also protect breast health!